Anti-C1orf103/LRIF1 Antibody Picoband® FITC Vervoeging

Predicted to enable nuclear retinoic acid receptor binding activity. Involved in dosage compensation by inactivation of X chromosome. Located in centriolar satellite; chromosome, telomeric region; and nuclear lumen. Implicated in facioscapulohumeral muscular dystrophy 3.

LRIF1; C1orf103; RIF1; Ligand-dependent nuclear receptor-interacting factor 1; HP1-binding protein enriched in inactive X chromosome protein 1; HBiX1; Receptor-interacting factor 1

LRIF1

55791

Q5T3J3

Human

No cross-reactivity with other proteins

E.coli-derived human C1orf103/LRIF1 recombinant protein (Position: Q157-D528) . Human C1orf103/LRIF1 shares 69% and 63.1% amino acid (aa) sequence identity with mouse and rat C1orf103/LRIF1, respectively.

Flow Cytometry

Immunogen affinity purified.

Liquid

1. Hamanaka, K., Sikrova, D., Mitsuhashi, S., Masuda, H., Sekiguchi, Y., Sugiyama, A., Shibuya, K., Lemmers, R. J. L. F., Goossens, R., Ogawa, M., Nagao, K., Obuse, C., Noguchi, S, Hayashi, Y. K., Kuwabara, S., Balog, J., Nishino, I., van der Maarel, S. M. Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology 94: e2441-e2447, 2020. 2. Li, H. J., Haque, Z. K., Chen, A., Mendelsohn, M. RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix. J. Cell. Biochem. 102: 1021-1035, 2007.

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

85 kDa

6

Ligand dependent nuclear receptor interacting factor 1

Ligand-dependent nuclear receptor-interacting factor 1

Rabbit IgG

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.